[HTML][HTML] A landscape of driver mutations in melanoma
…, DL Morton, K Stemke-Hale, G Chen, M Noble… - Cell, 2012 - cell.com
Despite recent insights into melanoma genetics, systematic surveys for driver mutations are
challenged by an abundance of passenger mutations caused by carcinogenic UV light …
challenged by an abundance of passenger mutations caused by carcinogenic UV light …
Mutational heterogeneity in cancer and the search for new cancer-associated genes
…, ML Cortés, D Auclair, G Saksena, D Voet, M Noble… - Nature, 2013 - nature.com
Major international projects are underway that are aimed at creating a comprehensive catalogue
of all the genes responsible for the initiation and progression of cancer 1 , 2 , 3 , 4 , 5 , 6 …
of all the genes responsible for the initiation and progression of cancer 1 , 2 , 3 , 4 , 5 , 6 …
[PDF][PDF] The immune landscape of cancer
…, J Kim, MS Lawrence, P Lin, S Meier, MS Noble… - Immunity, 2018 - cell.com
We performed an extensive immunogenomic analysis of more than 10,000 tumors comprising
33 diverse cancer types by utilizing data compiled by TCGA. Across cancer types, we …
33 diverse cancer types by utilizing data compiled by TCGA. Across cancer types, we …
[PDF][PDF] Integrated genomic characterization of papillary thyroid carcinoma
…, AJ Mungall, BA Murray, YE Nikiforov, MS Noble… - Cell, 2014 - cell.com
Papillary thyroid carcinoma (PTC) is the most common type of thyroid cancer. Here, we
describe the genomic landscape of 496 PTCs. We observed a low frequency of somatic …
describe the genomic landscape of 496 PTCs. We observed a low frequency of somatic …
[PDF][PDF] An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics
…, J Kim, MS Lawrence, P Lin, S Meier, MS Noble… - Cell, 2018 - cell.com
For a decade, The Cancer Genome Atlas (TCGA) program collected clinicopathologic
annotation data along with multi-platform molecular profiles of more than 11,000 human tumors …
annotation data along with multi-platform molecular profiles of more than 11,000 human tumors …
[PDF][PDF] Oncogenic signaling pathways in the cancer genome atlas
…, J Kim, MS Lawrence, P Lin, S Meier, MS Noble… - Cell, 2018 - cell.com
Genetic alterations in signaling pathways that control cell-cycle progression, apoptosis, and
cell growth are common hallmarks of cancer, but the extent, mechanisms, and co-…
cell growth are common hallmarks of cancer, but the extent, mechanisms, and co-…
[PDF][PDF] Comprehensive characterization of cancer driver genes and mutations
…, DI Heiman, MS Lawrence, P Lin, S Meier, MS Noble… - Cell, 2018 - cell.com
Identifying molecular cancer drivers is critical for precision oncology. Multiple advanced
algorithms to identify drivers now exist, but systematic attempts to combine and optimize them on …
algorithms to identify drivers now exist, but systematic attempts to combine and optimize them on …
[PDF][PDF] Cell-of-origin patterns dominate the molecular classification of 10,000 tumors from 33 types of cancer
…, G Getz, DI Heiman, J Kim, P Lin, S Meier, MS Noble… - Cell, 2018 - cell.com
We conducted comprehensive integrative molecular analyses of the complete set of tumors
in The Cancer Genome Atlas (TCGA), consisting of approximately 10,000 specimens and …
in The Cancer Genome Atlas (TCGA), consisting of approximately 10,000 specimens and …
[PDF][PDF] Comprehensive and integrative genomic characterization of hepatocellular carcinoma
…, G Saksena, CS Pedamallu, L Chin, G Getz, M Noble… - Cell, 2017 - cell.com
Liver cancer has the second highest worldwide cancer mortality rate and has limited
therapeutic options. We analyzed 363 hepatocellular carcinoma (HCC) cases by whole-exome …
therapeutic options. We analyzed 363 hepatocellular carcinoma (HCC) cases by whole-exome …
[PDF][PDF] Molecular profiling reveals biologically discrete subsets and pathways of progression in diffuse glioma
…, AJ Mungall, R Naresh, T Naska, L Neder, MS Noble… - Cell, 2016 - cell.com
Therapy development for adult diffuse glioma is hindered by incomplete knowledge of somatic
glioma driving alterations and suboptimal disease classification. We defined the complete …
glioma driving alterations and suboptimal disease classification. We defined the complete …